Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:1.5.7.1 (methylenetetrahydrofolate reductase)
 2,116 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The causes of spermatogenetic failure found in most cases of non-ohstmctive azoospermia or severe oligospermia remain largely unclear. It is estimated that in about 30% of the cases, male infertility is due to genetic causes, including chromosomal abnormalities, Y chromosome microdeletions, gene mutations, etc. Klinefelter's syndrome and microdeletions in the Y chromosome long arm (Yq) represent the most frequent molecular genetic cause of severe infertility. Gene mutations involved in male infertility include the cystic fibrosis transmembrane conductance regulator (CFTR) gene, androgen receptor (AR) gene, insulin-like factor 3 (INSL3) gene and leucine-rich repeat-containing G-protein coupled receptor 8 (LGR8) gene. CFTR mutations cause cystic fibrosis, absence of vas deferens and non-obstructive azoospermia. The AR gene mutations are responsible for the androgen insensitivity syndrome and spermatogenetic damage. And INSL3 and LGR8 gene mutations have been associated with abnormalities in testis descent and cryptorchidism. Meta-analyses have revealed a significant association between the polymorphism and male infertility only for partial AZFc deletion, CAG repeat length in the AR gene and methylenetetrahydrofolate reductase (MTHFR) gene. This paper mainly reviews the genetic causes of male infertility and the genetic polymorphisms possibly associated with male infertility.
 ...
PMID:[Genetic causes of male infertility]. 1900 17

Polymorphisms in the genes encoding enzymes in the folate metabolism pathway have been associated with male infertility and chromosome abnormalities. The aim of this study was to analyze the distribution of the methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), and methionine synthase reductase (MTRR) polymorphisms in fertile men and infertile men with non-obstructive azoospermia (NOA). A case-control study comprising 85 infertile men with NOA and 246 fertile men as controls was carried out. MTHFR c.677C > T (rs1801133), MTHFR c.1298A > C (rs1801131), MTR c.2756A > G (rs1805087), and MTRR c.66A > G (rs1801394) polymorphisms were determined using the polymerase chain reaction restriction fragment length polymorphism technique. There were significant differences in AC + CC genotype (OR = 1.9, 95% CI = 1.1-3.2) and C allele frequencies (OR = 1.8, 95% CI = 1.2-2.8) of MTHFR c.1298A > C polymorphism between NOA patients and controls after applying the Bonferroni correction. Moreover, the 1298AC genotype, 1298AC + CC genotype, and 1298C allele frequencies were statistically significant in NOA with chromosomal abnormalities and/or a Y chromosome deletion compared to the controls (AC genotype: OR = 3.0; AC + CC genotype: OR = 3.0; C allele: OR = 2.3). Considering the other polymorphisms, no differences were found between cases and controls. Our findings suggest the MTHFR c.1298A > C polymorphism is associated with an increased risk of male infertility, i.e., NOA.
 ...
PMID:Association between genetic polymorphisms in folate-related enzyme genes and infertile men with non-obstructive azoospermia. 2619 53